Literature DB >> 18080710

The need for anticoagulation following inferior vena cava filter placement: systematic review.

Charles E Ray1, Allan Prochazka.   

Abstract

PURPOSE: To perform a systemic review to determine the effect of anticoagulation on the rates of venous thromboembolism (pulmonary embolus, deep venous thrombosis, inferior vena cava (IVC) filter thrombosis) following placement of an IVC filter.
METHODS: A comprehensive computerized literature search was performed to identify relevant articles. Data were abstracted by two reviewers. Studies were included if it could be determined whether or not subjects received anticoagulation following filter placement, and if follow-up data were presented. A meta-analysis of patients from all included studies was performed. A total of 14 articles were included in the final analysis, but the data from only nine articles could be used in the meta-analysis; five studies were excluded because they did not present raw data which could be analyzed in the meta-analysis. A total of 1,369 subjects were included in the final meta-analysis.
RESULTS: The summary odds ratio for the effect of anticoagulation on venous thromboembolism rates following filter deployment was 0.639 (95% CI 0.351 to 1.159, p = 0.141). There was significant heterogeneity in the results from different studies [Q statistic of 15.95 (p = 0.043)]. Following the meta-analysis, there was a trend toward decreased venous thromboembolism rates in patients with post-filter anticoagulation (12.3% vs. 15.8%), but the result failed to reach statistical significance.
CONCLUSION: Inferior vena cava filters can be placed in patients who cannot receive concomitant anticoagulation without placing them at significantly higher risk of development of venous thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080710     DOI: 10.1007/s00270-007-9244-x

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  10 in total

1.  Inferior vena cava filtration in the management of venous thromboembolism: filtering the data.

Authors:  Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

Review 2.  Iatrogenic percutaneous vascular injuries: clinical presentation, imaging, and management.

Authors:  Benjamin H Ge; Alexander Copelan; Dominic Scola; Micah M Watts
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 3.  Procedural and indwelling complications with inferior vena cava filters: frequency, etiology, and management.

Authors:  Lazar Milovanovic; Sean A Kennedy; Mehran Midia
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

4.  Improving the tracking and removal of retrievable inferior vena cava filters.

Authors:  Anthony D Goei; Shellie C Josephs; Thomas B Kinney; Charles E Ray; David Sacks
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 5.  Inferior vena cava filters: current best practices.

Authors:  Anita Rajasekhar
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

6.  Perioperative Considerations in Metastatic Renal Cell Carcinoma.

Authors:  Kate Flavin; Nikhil Vasdev; Jim Ashead; Tim Lane; Damian Hanbury; Paul Nathan; Shanmugasundaram Gowrie-Mohan
Journal:  Rev Urol       Date:  2016

7.  Management of the thrombosed filter-bearing inferior vena cava.

Authors:  Onur Sildiroglu; Harun Ozer; Ulku Cenk Turba
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

8.  Development of a postoperative occlusive thrombus at the site of an implanted inferior vena cava filter: A case report.

Authors:  Ayako Kukida; Yasushi Takasaki; Mio Nakata; Tasuku Nishihara; Sakiko Kitamura; Sonoko Fujii; Yuji Watanabe; Toshihiro Yorozuya
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

9.  Outcome of anticoagulation with rivaroxaban in patients with non-retrieved inferior vena cava filters for the prevention of filter thrombosis: a retrospective cohort study.

Authors:  Baoyan Wang; Chenxiao Jiang; Yepeng Zhang; Xiaoqiang Li; Hang Xu
Journal:  BMC Cardiovasc Disord       Date:  2022-09-11       Impact factor: 2.174

10.  Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy.

Authors:  Honghong Zou; Yebei Li; Gaosi Xu
Journal:  BMC Nephrol       Date:  2019-12-02       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.